Standout Papers

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease 2019 2026 2021 2023 915
  1. Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease (2019)
    Oliver Distler, Kristin B. Highland et al. New England Journal of Medicine

Immediate Impact

3 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

Fibrosis in IBD: from pathogenesis to therapeutic targets
2024 Standout
Endogenous stimuli-responsive separating microneedles to inhibit hypertrophic scar through remodeling the pathological microenvironment
2024 Standout
2 intermediate papers

Works of Margarida Alves being referenced

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout

Author Peers

Author Last Decade Papers Cites
Margarida Alves 979 1139 460 30 1.4k
Martina Gahlemann 911 1318 431 25 1.6k
M Girard 695 899 314 21 1.2k
Rachel K. Hoyles 741 949 339 24 1.3k
Torhild Garen 815 817 613 39 1.5k
CP Denton 888 713 183 30 1.3k
Carl Coeck 418 1426 283 18 1.6k
Gregory J. Keir 346 1290 321 34 1.4k
R.M. duBois 264 937 212 15 1.3k
Eleanor Valenzi 388 966 221 25 1.4k
A Wiik 410 465 230 37 1.2k

All Works

Loading papers...

Rankless by CCL
2026